Stop Gambling in the Stock Market. Be an intelligent and confident investor.
See what the professionals see with financial analytics, charts and valuation models.
Fundamental Analysis and Stock Valuation Simplified. Learn more.

Divis Laboratories Ltd. | DIVISLAB | NSE - Pharmaceuticals


Performance Trend  |  Valuation  |  Growth  |  Insiders  |  Summary
Balance Sheet  |  Income Statement  |  Cash Flow  |  Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated.

Upgrade Membership to see 10 year accruate financial statements.

  
2015
2016
2017
2018
2019
Net Income
Net Income
10,721
13,781
13,953
12,313
18,551
Cash flow Operating Act...
Cash flow Operating Activities
8,26310,37911,4937,7599,543
Investments in PPE
Investments in PPE
-3,072-3,957-3,767-2,739-7,331
Cash flow Investing Act...
Net cash used for Investment Activities
-5,208-4,135-11,372-4,783-6,854
Cash flow Financing Act...
Net cash provided by Financing Activities
-3,030-6,241-93-3,142-2,459
Cash at beginning of period
Cash at beginning of period
151176179-43-209
Cash at end of period
Cash at end of period
176179208-20921
Free Cash Flow
Free Cash Flow
5,191
6,422
7,726
5,020
2,212